Company Monitoring Page for Amgen

latest headlines for company on cafepharma

CVS Health says Amgen data may increase eligible patients by millions
Yahoo/Reuters
Sun, 03/19/17 - 10:37 am
Tags:
CVS Health, Amgen, Repatha, patients
Amgen Drug Prevents Heart Attacks, Not Deaths, Disappointing Experts
Forbes
Fri, 03/17/17 - 11:33 am
Tags:
Amgen, Repatha, heart attacks, stroke, clinical trials
Heart attack while on Repatha? Amgen will give you your money back
Endpoints
Fri, 03/17/17 - 11:21 am
Tags:
Repatha, Amgen, heart attack, drug pricing
Amgen cholesterol drug cuts heart attack, stroke risk more than 20 pct-study
Yahoo/Reuters
Fri, 03/17/17 - 11:19 am
Tags:
Amgen, Repatha, heart attack, stroke, LDL cholesterol
Data on heart benefits of Amgen drug is key to unlocking sales
Yahoo/Reuters
Mon, 03/13/17 - 10:04 am
Tags:
Amgen, Repatha, heart disease
Amgen launches new Repatha DTC ad
Medical Marketing and Media
Tue, 03/7/17 - 11:53 am
Tags:
Amgen, DTC advertising, drug ads, Repatha
Amgen accuses would-be copycat Coherus of stealing its Neulasta secrets
Fierce Pharma
Tue, 03/7/17 - 11:52 am
Tags:
Coherus Biosciences, Amgen, Neulasta, biosimilars
Amgen: Clinical Trials Set Stage for Further Upside
TheStreet.com
Fri, 03/3/17 - 10:42 pm
Tags:
Amgen, clinical trials, Repatha
The Demise of the BPCIA Patent Dance?
FDA Law Blog
Fri, 03/3/17 - 09:40 am
Tags:
BPCIA, patents, Genentech, Amgen, Sandoz, Avastin
Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study
Yahoo/Reuters
Tue, 02/28/17 - 11:12 am
Tags:
Amgen, Kyprolis, Velcade, Takeda, Multiple Myeloma
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Investopedia
Thu, 02/23/17 - 09:39 pm
Tags:
Amgen, Enbrel, rheumatoid arthritis
In Amgen-Sandoz SCOTUS case, biosim makers lambaste ruling's 6-month exclusivity gift
Fierce Pharma
Wed, 02/22/17 - 09:44 am
Tags:
Amgen, Sandoz, Supreme Court, biosimilars
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Tags:
Amgen, patents, BPCIA, FDA, Sandoz, Neupogen, generics, Genentech, Avastin
With Siliq approval, can Amgen and AZ's trash become Valeant's treasure?
Fierce Pharma
Thu, 02/16/17 - 10:11 am
Tags:
Siliq, Amgen, AstraZeneca, Valeant Pharmaceuticals, chronic plaque psoriasis
Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Tags:
Sanofi, Praluent, Regeneron, Amgen, Repatha
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Tags:
Sanofi, Regeneron, Praluent, Amgen, Repatha
FDA approves Amgen drug for secondary hyperparathyroidism
Yahoo/Reuters
Wed, 02/8/17 - 09:18 am
Tags:
FDA, Amgen, secondary hyperparathyroidism, kidney disease, etelcalcetide
Amgen's Repatha wins in outcomes trial, but is the score high enough?
Fierce Pharma
Mon, 02/6/17 - 12:04 pm
Tags:
Amgen, Repatha, drug launches
New outcomes data could unlock Repatha's potential, says Amgen
PM Live
Mon, 02/6/17 - 12:01 pm
Tags:
Repatha, Amgen
Amgen: Who Says Biotech’s Dead?
Barron's
Sat, 02/4/17 - 09:57 am
Tags:
Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.